FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 323:579-584 August 30, 1990 Number 9 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

BACKGROUND AND METHODS. Patients with the nephrotic syndrome characteristically have multiple abnormalities of lipoprotein metabolism, but the cause and exact nature of these abnormalities are uncertain. In this study, we measured serum lipids and apoproteins in 57 patients with the nephrotic syndrome. We also determined the kinetic indexes of low-density lipoprotein (LDL) metabolism in six patients, and again in three of the six after recovery. RESULTS. The patients with the nephrotic syndrome had elevated serum concentrations of cholesterol, triglycerides, and phospholipids, which were confined to the lipoproteins containing apoprotein B. The serum concentrations of high-density lipoproteins and the associated A-I and A-II apoproteins were similar in the patients with the nephrotic syndrome and normal subjects. The relative proportions of lipids and their positive association with the increased serum concentrations of apoproteins B, C-II, C-III, and E suggest quantitative rather than qualitative differences in the lipoproteins. All the patients had lipiduria, which probably reflected the excretion of high-density lipoproteins, although no intact immunoreactive apoprotein A-I was found in urine. Serum albumin concentrations were inversely related to serum lipid concentrations in the patients, the severity of the hypoalbuminemia corresponding to the degree of change in serum lipoprotein concentrations. The kinetic studies of lipoprotein metabolism revealed an overproduction of LDL apoprotein B that returned to normal after recovery. CONCLUSIONS. The elevated serum concentrations of LDL cholesterol, other lipids, and apoprotein B in patients with uncomplicated nephrotic syndrome are due to reversible increases in lipoprotein production.

Source Information

Centre de Recerca Biomedica del Hospital de Sant Joan, Reus, Spain.

This article has been cited by other articles:

• Zhou, Y., Zhang, X., Chen, L., Wu, J., Dang, H., Wei, M., Fan, Y., Zhang, Y., Zhu, Y., Wang, N., Breyer, M. D., Guan, Y. (2008). Expression profiling of hepatic genes associated with lipid metabolism in nephrotic rats. Am. J. Physiol. Renal Physiol. 295: F662-F671 [Abstract] [Full Text]  
• Kelly, K. J., Wu, P., Patterson, C. E., Temm, C., Dominguez, J. H. (2008). LOX-1 and inflammation: a new mechanism for renal injury in obesity and diabetes. Am. J. Physiol. Renal Physiol. 294: F1136-F1145 [Abstract] [Full Text]  
• Mahmoodi, B. K., ten Kate, M. K., Waanders, F., Veeger, N. J.G.M., Brouwer, J.-L. P., Vogt, L., Navis, G., van der Meer, J. (2008). High Absolute Risks and Predictors of Venous and Arterial Thromboembolic Events in Patients With Nephrotic Syndrome: Results From a Large Retrospective Cohort Study. Circulation 117: 224-230 [Abstract] [Full Text]  
• Vogt, L., Laverman, G. D., van Tol, A., Groen, A. K., Navis, G., Dullaart, R. P. F. (2006). Cellular cholesterol efflux to plasma from proteinuric patients is elevated and remains unaffected by antiproteinuric treatment. Nephrol Dial Transplant 21: 101-106 [Abstract] [Full Text]  
• Kim, S., Kim, C. H., Vaziri, N. D. (2005). Upregulation of hepatic LDL receptor-related protein in nephrotic syndrome: response to statin therapy. Am. J. Physiol. Endocrinol. Metab. 288: E813-E817 [Abstract] [Full Text]  
• Vaziri, N.D., Liang, K.H. (2004). Acyl-Coenzyme A:Cholesterol Acyltransferase Inhibition Ameliorates Proteinuria, Hyperlipidemia, Lecithin-Cholesterol Acyltransferase, SRB-1, and Low-Denisty Lipoprotein Receptor Deficiencies in Nephrotic Syndrome. Circulation 110: 419-425 [Abstract] [Full Text]  
• Vogt, L., Laverman, G. D., Dullaart, R. P. F., Navis, G. (2004). Lipid management in the proteinuric patient: do not overlook the importance of proteinuria reduction. Nephrol Dial Transplant 19: 5-8 [Full Text]  
• Ruggenenti, P., Mise, N., Pisoni, R., Arnoldi, F., Pezzotta, A., Perna, A., Cattaneo, D., Remuzzi, G. (2003). Diverse Effects of Increasing Lisinopril Doses on Lipid Abnormalities in Chronic Nephropathies. Circulation 107: 586-592 [Abstract] [Full Text]  
• Tovar, A. R., Murguia, F., Cruz, C., Hernandez-Pando, R., Aguilar-Salinas, C. A., Pedraza-Chaverri, J., Correa-Rotter, R., Torres, N. (2002). A Soy Protein Diet Alters Hepatic Lipid Metabolism Gene Expression and Reduces Serum Lipids and Renal Fibrogenic Cytokines in Rats with Chronic Nephrotic Syndrome. J. Nutr. 132: 2562-2569 [Abstract] [Full Text]  
• Al Suwaidi, J., Reddan, D. N., Williams, K., Pieper, K. S., Harrington, R. A., Califf, R. M., Granger, C. B., Ohman, E. M., Holmes, D. R. Jr, for the GUSTO-IIb, GUSTO-III, PURSUIT, and PARAGON, (2002). Prognostic Implications of Abnormalities in Renal Function in Patients With Acute Coronary Syndromes. Circulation 106: 974-980 [Abstract] [Full Text]  
• Hartland, A J, Giles, P D, Bridger, J E, Simmons, W (2002). A case of membranous glomerulonephritis presenting as pulmonary embolism and acute hyperlipidaemia. J. Clin. Pathol. 55: 538-540 [Abstract] [Full Text]  
• Ozata, M., Oktenli, C., Gulec, M., Ozgurtas, T., Bulucu, F., Caglar, K., Bingol, N., Vural, A., Ozdemir, I. C. (2002). Increased Fasting Plasma Acylation-Stimulating Protein Concentrations in Nephrotic Syndrome. J. Clin. Endocrinol. Metab. 87: 853-858 [Abstract] [Full Text]  
• Formiga, F, Meco, J F, Pinto, X, Jacob, J, Moga, I, Pujol, R (2001). Lipid and lipoprotein levels in premenopausal systemic lupus erythematosus patients. Lupus 10: 359-363 [Abstract]  
• Zanetti, M., Barazzoni, R., Garibotto, G., Davanzo, G., Gabelli, C., Kiwanuka, E., Piccoli, A., Tosolini, M., Tessari, P. (2001). Plasma protein synthesis in patients with low-grade nephrotic proteinuria. Am. J. Physiol. Endocrinol. Metab. 280: E591-E597 [Abstract] [Full Text]  
• Clark, W F, Moist, L M (1998). Management of chronic renal insufficiency in lupus nephritis: Role of proteinuria, hypertension and dyslipidemia in the progression of renal disease. Lupus 7: 649-653 [Abstract]  
• Orth, S. R., Ritz, E. (1998). The Nephrotic Syndrome. NEJM 338: 1202-1211 [Full Text]  
• Berglund, L., Witztum, J. L., Galeano, N. F., Khouw, A. S., Ginsberg, H. N., Ramakrishnan, R. (1998). Three-fold effect of lovastatin treatment on low density lipoprotein metabolism in subjects with hyperlipidemia: increase in receptor activity, decrease in apoB production, and decrease in particle affinity for the receptor. Results from a novel triple-tracer approach. J. Lipid Res. 39: 913-924 [Abstract] [Full Text]  
• Braschi, S., Masson, D., Rostoker, G., Florentin, E., Athias, A., Martin, C., Jacotot, B., Gambert, P., Lallemant, C., Lagrost, L. (1997). Role of Lipoprotein-Bound NEFAs in Enhancing the Specific Activity of Plasma CETP in the Nephrotic Syndrome. Arterioscler. Thromb. Vasc. Bio. 17: 2559-2567 [Abstract] [Full Text]  
• Maugeais, C., Braschi, S., Ouguerram, K., Maugeais, P., Mahot, P., Jacotot, B., Darmaun, D., Magot, T., Krempf, M. (1997). Lipoprotein Kinetics in Patients With Analbuminemia : Evidence for the Role of Serum Albumin in Controlling Lipoprotein Metabolism. Arterioscler. Thromb. Vasc. Bio. 17: 1369-1375 [Abstract] [Full Text]  
• Joven, J., Cliville, X., Camps, J., Espinel, E., Simo, J., Vilella, E., Oliver, A. (1997). Plasma protein abnormalities in nephrotic syndrome: effect on plasma colloid osmotic pressure and viscosity. Clin. Chem. 43: 1223-1231 [Abstract] [Full Text]  
• Braschi, S., Lagrost, L., Florentin, E., Martin, C., Athias, A., Gambert, P., Krempf, M., Lallemant, C., Jacotot, B. (1996). Increased Cholesteryl Ester Transfer Activity in Plasma From Analbuminemic Patients. Arterioscler. Thromb. Vasc. Bio. 16: 441-449 [Abstract] [Full Text]